| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiologists | 9 | 2025 | 88 | 5.340 |
Why?
|
| Radiology | 18 | 2024 | 252 | 4.620 |
Why?
|
| Diagnostic Imaging | 9 | 2020 | 264 | 1.850 |
Why?
|
| Communication | 7 | 2019 | 573 | 1.690 |
Why?
|
| Salaries and Fringe Benefits | 4 | 2020 | 38 | 1.630 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2025 | 1613 | 1.590 |
Why?
|
| Internship and Residency | 5 | 2021 | 801 | 1.210 |
Why?
|
| Appendicitis | 4 | 2015 | 81 | 1.040 |
Why?
|
| Radiography, Thoracic | 2 | 2025 | 116 | 0.970 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2025 | 17 | 0.920 |
Why?
|
| Lymphadenopathy | 2 | 2021 | 23 | 0.870 |
Why?
|
| Diagnostic Errors | 1 | 2025 | 98 | 0.860 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 51 | 0.850 |
Why?
|
| Cultural Diversity | 1 | 2024 | 53 | 0.840 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 670 | 0.820 |
Why?
|
| Conscious Sedation | 2 | 2019 | 39 | 0.810 |
Why?
|
| Practice Guidelines as Topic | 8 | 2014 | 736 | 0.730 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2021 | 94 | 0.730 |
Why?
|
| Learning | 1 | 2023 | 182 | 0.710 |
Why?
|
| Physician-Patient Relations | 3 | 2014 | 421 | 0.710 |
Why?
|
| Radiology Information Systems | 2 | 2019 | 34 | 0.700 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 185 | 0.700 |
Why?
|
| Simulation Training | 2 | 2019 | 65 | 0.700 |
Why?
|
| Radiology, Interventional | 2 | 2019 | 32 | 0.690 |
Why?
|
| Humans | 52 | 2025 | 63283 | 0.680 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 211 | 0.670 |
Why?
|
| Teleradiology | 1 | 2020 | 3 | 0.670 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 225 | 0.660 |
Why?
|
| Academic Medical Centers | 3 | 2019 | 318 | 0.650 |
Why?
|
| Health Information Exchange | 1 | 2019 | 4 | 0.610 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 8 | 0.590 |
Why?
|
| Curriculum | 4 | 2021 | 591 | 0.580 |
Why?
|
| Radiographic Image Enhancement | 3 | 2014 | 98 | 0.570 |
Why?
|
| Anatomy | 1 | 2017 | 17 | 0.560 |
Why?
|
| Demography | 1 | 2017 | 173 | 0.550 |
Why?
|
| Cadaver | 1 | 2017 | 128 | 0.540 |
Why?
|
| Abdominal Pain | 2 | 2015 | 102 | 0.540 |
Why?
|
| Pandemics | 3 | 2021 | 674 | 0.530 |
Why?
|
| Quality Improvement | 2 | 2019 | 442 | 0.510 |
Why?
|
| Patient Simulation | 1 | 2016 | 72 | 0.500 |
Why?
|
| Educational Measurement | 2 | 2019 | 217 | 0.500 |
Why?
|
| Education, Medical | 1 | 2017 | 181 | 0.490 |
Why?
|
| Medicare | 1 | 2020 | 610 | 0.480 |
Why?
|
| United States | 14 | 2024 | 7828 | 0.480 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 715 | 0.470 |
Why?
|
| Radiography | 3 | 2021 | 548 | 0.460 |
Why?
|
| Foot Injuries | 1 | 2014 | 6 | 0.460 |
Why?
|
| Computer Graphics | 1 | 2014 | 19 | 0.450 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 71 | 0.440 |
Why?
|
| Patient Access to Records | 1 | 2014 | 3 | 0.430 |
Why?
|
| Radiation Dosage | 2 | 2018 | 132 | 0.430 |
Why?
|
| Radiometry | 1 | 2014 | 36 | 0.430 |
Why?
|
| Documentation | 1 | 2014 | 128 | 0.420 |
Why?
|
| Truth Disclosure | 1 | 2014 | 57 | 0.420 |
Why?
|
| Fractures, Bone | 1 | 2014 | 143 | 0.410 |
Why?
|
| Abdomen, Acute | 3 | 2014 | 23 | 0.390 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 288 | 0.390 |
Why?
|
| Radiation Effects | 1 | 2011 | 2 | 0.370 |
Why?
|
| Patient Preference | 1 | 2012 | 84 | 0.370 |
Why?
|
| Ambulatory Care Facilities | 1 | 2012 | 105 | 0.370 |
Why?
|
| Software | 1 | 2014 | 389 | 0.350 |
Why?
|
| Female | 21 | 2025 | 32776 | 0.350 |
Why?
|
| Mammography | 1 | 2014 | 280 | 0.350 |
Why?
|
| Angiography | 1 | 2011 | 152 | 0.350 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 1146 | 0.340 |
Why?
|
| Mortality | 2 | 2024 | 160 | 0.330 |
Why?
|
| Radiography, Interventional | 2 | 2017 | 74 | 0.310 |
Why?
|
| Societies, Medical | 3 | 2018 | 376 | 0.300 |
Why?
|
| Male | 18 | 2025 | 29799 | 0.300 |
Why?
|
| Osteoarthritis, Hip | 1 | 2008 | 25 | 0.290 |
Why?
|
| Vena Cava Filters | 1 | 2008 | 23 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2008 | 72 | 0.280 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 280 | 0.280 |
Why?
|
| Fibrin | 1 | 2007 | 19 | 0.270 |
Why?
|
| Diagnosis, Differential | 5 | 2021 | 972 | 0.270 |
Why?
|
| Blood Coagulation | 1 | 2007 | 39 | 0.260 |
Why?
|
| Vascular Patency | 1 | 2007 | 139 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 2167 | 0.250 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 87 | 0.250 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2008 | 126 | 0.250 |
Why?
|
| Hospitalists | 1 | 2006 | 37 | 0.250 |
Why?
|
| Health Services Accessibility | 1 | 2011 | 563 | 0.250 |
Why?
|
| Renal Dialysis | 1 | 2007 | 198 | 0.240 |
Why?
|
| Referral and Consultation | 3 | 2020 | 422 | 0.240 |
Why?
|
| Risk Assessment | 5 | 2020 | 2071 | 0.230 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1199 | 0.230 |
Why?
|
| Aged, 80 and over | 8 | 2014 | 5443 | 0.220 |
Why?
|
| Appendectomy | 2 | 2003 | 54 | 0.220 |
Why?
|
| Middle Aged | 11 | 2025 | 17535 | 0.220 |
Why?
|
| Morbidity | 1 | 2024 | 113 | 0.220 |
Why?
|
| Congresses as Topic | 1 | 2024 | 79 | 0.210 |
Why?
|
| Health Equity | 1 | 2024 | 46 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2025 | 3280 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 1649 | 0.200 |
Why?
|
| Osteoarthritis, Knee | 1 | 2008 | 385 | 0.200 |
Why?
|
| Aged | 10 | 2020 | 14384 | 0.200 |
Why?
|
| Health Status Disparities | 1 | 2024 | 145 | 0.200 |
Why?
|
| Acute Disease | 5 | 2015 | 672 | 0.190 |
Why?
|
| Hypnosis | 1 | 2002 | 3 | 0.190 |
Why?
|
| Emergencies | 1 | 2002 | 116 | 0.190 |
Why?
|
| Clinical Competence | 2 | 2025 | 725 | 0.190 |
Why?
|
| Stroke | 1 | 2011 | 1191 | 0.190 |
Why?
|
| Colonography, Computed Tomographic | 3 | 2014 | 20 | 0.180 |
Why?
|
| Museums | 1 | 2021 | 3 | 0.180 |
Why?
|
| Ultrasonography | 2 | 2015 | 483 | 0.180 |
Why?
|
| Natural Language Processing | 1 | 2021 | 47 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2004 | 268 | 0.170 |
Why?
|
| Sex Factors | 2 | 2017 | 979 | 0.170 |
Why?
|
| Appendix | 2 | 2015 | 17 | 0.170 |
Why?
|
| Practice Management | 1 | 2020 | 2 | 0.170 |
Why?
|
| Diverticulitis | 1 | 2020 | 31 | 0.170 |
Why?
|
| Arkansas | 1 | 2020 | 4 | 0.170 |
Why?
|
| Federal Government | 1 | 2020 | 19 | 0.170 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 16 | 0.170 |
Why?
|
| Ownership | 1 | 2020 | 19 | 0.170 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 357 | 0.160 |
Why?
|
| Language | 1 | 2021 | 150 | 0.160 |
Why?
|
| Age Factors | 2 | 2017 | 1560 | 0.160 |
Why?
|
| Lung | 1 | 2025 | 953 | 0.160 |
Why?
|
| Ambulatory Care | 1 | 2002 | 311 | 0.160 |
Why?
|
| Income | 1 | 2020 | 169 | 0.150 |
Why?
|
| Pancreatitis | 2 | 2014 | 97 | 0.150 |
Why?
|
| Workplace | 1 | 2020 | 172 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2003 | 491 | 0.150 |
Why?
|
| Radiation Monitoring | 1 | 2018 | 4 | 0.150 |
Why?
|
| Vaccination | 1 | 2021 | 363 | 0.150 |
Why?
|
| Patient Readmission | 2 | 2017 | 430 | 0.150 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 417 | 0.140 |
Why?
|
| Adult | 10 | 2019 | 16771 | 0.140 |
Why?
|
| Dissection | 1 | 2017 | 48 | 0.140 |
Why?
|
| Tissue Donors | 1 | 2017 | 152 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2020 | 6627 | 0.130 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 137 | 0.130 |
Why?
|
| Cause of Death | 1 | 2017 | 221 | 0.130 |
Why?
|
| Inpatients | 1 | 2019 | 303 | 0.130 |
Why?
|
| Incidence | 1 | 2020 | 1375 | 0.130 |
Why?
|
| Fractures, Spontaneous | 1 | 2016 | 6 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 350 | 0.130 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 1093 | 0.120 |
Why?
|
| Patient Selection | 2 | 2012 | 488 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2019 | 358 | 0.120 |
Why?
|
| Teaching | 1 | 2016 | 159 | 0.120 |
Why?
|
| Massachusetts | 2 | 2020 | 2075 | 0.110 |
Why?
|
| Multidetector Computed Tomography | 1 | 2014 | 21 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 126 | 0.110 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 165 | 0.110 |
Why?
|
| Registries | 1 | 2018 | 884 | 0.110 |
Why?
|
| Barium Sulfate | 1 | 2014 | 18 | 0.110 |
Why?
|
| Enema | 1 | 2014 | 14 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 213 | 0.110 |
Why?
|
| Costs and Cost Analysis | 2 | 2006 | 102 | 0.110 |
Why?
|
| User-Computer Interface | 1 | 2014 | 125 | 0.110 |
Why?
|
| Cholecystitis | 1 | 2014 | 29 | 0.110 |
Why?
|
| Waiting Lists | 1 | 2014 | 50 | 0.110 |
Why?
|
| Jaundice | 1 | 2013 | 6 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2014 | 192 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 462 | 0.100 |
Why?
|
| Cholestasis | 1 | 2013 | 65 | 0.100 |
Why?
|
| Prevalence | 2 | 2019 | 1377 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2016 | 1006 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 1 | 2011 | 27 | 0.090 |
Why?
|
| Crohn Disease | 2 | 2010 | 111 | 0.090 |
Why?
|
| Radiology Department, Hospital | 1 | 2012 | 24 | 0.090 |
Why?
|
| Workflow | 1 | 2012 | 69 | 0.090 |
Why?
|
| Radiation Protection | 1 | 2011 | 26 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2012 | 192 | 0.090 |
Why?
|
| Data Collection | 1 | 2012 | 384 | 0.090 |
Why?
|
| Canada | 1 | 2011 | 155 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 319 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2569 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1359 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2012 | 568 | 0.080 |
Why?
|
| Survival Rate | 2 | 2010 | 850 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2460 | 0.080 |
Why?
|
| Models, Economic | 1 | 2008 | 44 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2008 | 123 | 0.070 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2008 | 42 | 0.070 |
Why?
|
| Adolescent | 3 | 2003 | 6238 | 0.070 |
Why?
|
| Length of Stay | 3 | 2006 | 811 | 0.070 |
Why?
|
| Alloys | 1 | 2007 | 29 | 0.070 |
Why?
|
| Elasticity | 1 | 2007 | 43 | 0.070 |
Why?
|
| Pain, Postoperative | 1 | 2008 | 163 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 2007 | 69 | 0.070 |
Why?
|
| Peritoneal Diseases | 1 | 2006 | 5 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2008 | 287 | 0.060 |
Why?
|
| Choristoma | 1 | 2006 | 22 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 311 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2012 | 690 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 87 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 57 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 2 | 2012 | 255 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 935 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 105 | 0.060 |
Why?
|
| Erythrocytes | 1 | 2006 | 149 | 0.060 |
Why?
|
| Hospital Costs | 1 | 2006 | 126 | 0.060 |
Why?
|
| Spleen | 1 | 2006 | 483 | 0.060 |
Why?
|
| Mass Screening | 1 | 2010 | 690 | 0.060 |
Why?
|
| Logistic Models | 1 | 2008 | 1275 | 0.060 |
Why?
|
| Thrombosis | 1 | 2007 | 199 | 0.060 |
Why?
|
| Decision Making | 1 | 2008 | 407 | 0.060 |
Why?
|
| Pregnancy | 1 | 2011 | 2330 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2003 | 25 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2004 | 41 | 0.050 |
Why?
|
| Internet | 2 | 2021 | 469 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2003 | 201 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1543 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2002 | 43 | 0.050 |
Why?
|
| Specialization | 1 | 2002 | 81 | 0.050 |
Why?
|
| Medicine | 1 | 2002 | 57 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2008 | 2566 | 0.050 |
Why?
|
| Decision Trees | 1 | 2002 | 51 | 0.050 |
Why?
|
| Boston | 1 | 2002 | 252 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2003 | 172 | 0.040 |
Why?
|
| Utilization Review | 1 | 2020 | 32 | 0.040 |
Why?
|
| Patient Admission | 1 | 2002 | 195 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 3757 | 0.040 |
Why?
|
| Research Design | 1 | 2004 | 573 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 734 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2008 | 5647 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2018 | 22 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 184 | 0.040 |
Why?
|
| Colonoscopy | 2 | 2010 | 97 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1168 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5338 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 303 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1084 | 0.020 |
Why?
|
| Data Display | 1 | 2012 | 6 | 0.020 |
Why?
|
| Product Labeling | 1 | 2012 | 9 | 0.020 |
Why?
|
| Software Design | 1 | 2012 | 28 | 0.020 |
Why?
|
| Efficiency | 1 | 2012 | 41 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2675 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 424 | 0.020 |
Why?
|
| Checklist | 1 | 2012 | 73 | 0.020 |
Why?
|
| Goals | 1 | 2012 | 91 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 126 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 502 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 134 | 0.020 |
Why?
|
| Safety Management | 1 | 2012 | 137 | 0.020 |
Why?
|
| Adenoma | 1 | 2010 | 69 | 0.020 |
Why?
|
| Occupational Health | 1 | 2012 | 187 | 0.020 |
Why?
|
| Medical Errors | 1 | 2012 | 195 | 0.020 |
Why?
|
| Leadership | 1 | 2012 | 206 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 74 | 0.020 |
Why?
|
| Patient Safety | 1 | 2012 | 243 | 0.020 |
Why?
|
| Biopsy | 1 | 2010 | 444 | 0.020 |
Why?
|
| Splenosis | 1 | 2006 | 1 | 0.020 |
Why?
|
| Splenectomy | 1 | 2006 | 42 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 198 | 0.010 |
Why?
|
| Pain | 1 | 2006 | 406 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 214 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 2002 | 18 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 281 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 1750 | 0.010 |
Why?
|